Dominance of variant A in Human Herpesvirus 6 viraemia after renal transplantation

Virology Journal

Volumn 8, Issue , 2011, Pages

  Csoma, Eszter ^a   Mészáros, Beáta ^a   Gáll, Tamás ^a   Asztalos, Lászlá ^b   Kánya, Jázsef ^a   Gergely, Lajos ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

HHV 6; renal transplantation; variant A

Indexed keywords

CALCINEURIN INHIBITOR; CYTOMEGALOVIRUS ANTIGEN PP65; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; VIRUS DNA; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT FAILURE; HERPES VIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6 VARIANT A; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; VIRUS LOAD; BLOOD; COMORBIDITY; EXANTHEMA SUBITUM; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; PREVALENCE; TRANSPLANTATION; VIREMIA; VIROLOGY;

HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6;

ADOLESCENT; ADULT; AGED; ANTIGENS, VIRAL; BLOOD; CHILD; COMORBIDITY; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; ROSEOLOVIRUS INFECTIONS; TRANSPLANTATION; VIREMIA; YOUNG ADULT;

EID: 80051579925     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-403     Document Type: Article

References (31)

1. Serological diagnosis of infection with human herpesvirus type 6. Irving WL, Cunningham AL, Br Med J 1990 300 156 159 10.1136/bmj.300.6718.156 (Pubitemid 20024560)
2. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Ablashi DV, Balachandran N, Josephs SF, Hung CL, Krueger GR, Kramarsky B, Salahuddin SZ, Gallo RC, Virology 1991 184 545 552 10.1016/0042-6822(91)90424-A 1653487
3. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. Dewhurst S, McIntyre K, Schnabel K, Hall CB, J Clin Microbiol 1993 31 416 418 8381815 (Pubitemid 23028652)
4. Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV. Fischer SA, Transplantation 2008 86 1327 1339 10.1097/TP.0b013e31818b6548 19033999
5. Human herpesvirus-6 in transplantation: an emerging pathogen. Singh N, Carrigan DR, Ann Intern Med 1996 124 1065 1071 8633821
6. Infection with human herpesvirus 6 after kidney-pancreas transplant. Benito N, Ricart MJ, Pumarola T, Marcos MA, Oppenheimer F, Camacho AM, Am J Transplant 2004 4 1197 1199 10.1111/j.1600-6143.2004.00449.x 15196082 (Pubitemid 38868615)
7. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolf P, Obert G, Clin Infect Dis 1996 22 171 173 10.1093/clinids/22.1.171 8824991 (Pubitemid 26022036)
8. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Rosenfeld CS, Rybka WB, Weinbaum D, Carrigan DR, Knox KK, Andrews DF, Shadduck RK, Exp Hematol 1995 23 626 629 7601254
9. Human herpesvirus-6 and -7 after lung and heart-lung transplantation. Lehto JT, Halme M, Tukiainen P, Harjula A, Sipponen J, Lautenschlager I, J Heart Lung Transplant 2007 26 41 47 10.1016/j.healun.2006.10.017 17234516 (Pubitemid 46096746)
10. Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis. Humar A, Transplantation 2006 82 9 S14 16858271
11. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. Lusso P, J Clin Virol 2006 37 Suppl 1 4 10 17276368
12. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. DesJardin JA, Gibbons L, Cho E, Supran SE, Falagas ME, Werner BG, Snydman DR, J Infect Dis 1998 178 1783 1786 10.1086/314510 9815234 (Pubitemid 28558154)
13. Post-transplant HHV-6 Diseases. Gentile G, Herpes 2000 7 24 27 11866997 (Pubitemid 30479580)
14. HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation. Harma M, Hockerstedt K, Lyytikainen O, Lautenschlager I, J Med Virol 2006 78 800 805 10.1002/jmv.20626 16628583
15. Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation. Ratnamohan VM, Chapman J, Howse H, Bovington K, Robertson P, Byth K, Allen R, Cunningham AL, Transplantation 1998 66 877 882 10.1097/00007890-199810150-00011 9798697 (Pubitemid 28487461)
16. Human herpesviruses-6, -7 and -8 in organ transplant recipients. Singh N, Clin Microbiol Infect 2000 6 453 459 10.1046/j.1469-0691.2000.00129.x 11168178 (Pubitemid 34966063)
17. Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. Ljungman P, Singh N, J Clin Virol 2006 37 Suppl 1 87 91 17276376
18. Human herpesvirus 6: An emerging pathogen. Campadelli-Fiume G, Mirandola P, Menotti L, Emerg Infect Dis 1999 5 353 366 10.3201/eid0503.990306 10341172 (Pubitemid 29289449)
19. Transmission of chromosomally integrated human herpesvirsus 6 (HHV-6) variant A from a parent to children leading to misdiagnosis of active HHV-6 infection. Mori T, Tanaka-Taya K, Satoh H, Aisa Y, Yamazaki R, Kato J, Ikeda Y, Okamoto S, Transpl Infect Dis 2009 11 503 506 10.1111/j.1399-3062.2009.00430.x 19656346
20. Human herpesvirus 6 infection after solid organ transplantation. Bakran A, Hart IJ, Transplantation 2009 88 757 758 10.1097/TP.0b013e3181b4452b 19920771
21. Molecular monitoring of viral infections after hematopoietic stem cell transplantation. Ljungman P, Int J Hematol 2010 91 596 601 10.1007/s12185-010- 0570-4 20414752
22. Human herpesvirus 6 infections after liver transplantation. Abdel Massih RC, Razonable RR, World J Gastroenterol 2009 15 2561 2569 10.3748/wjg.15.2561 19496184
23. Transplacental congenital human herpesvirus 6 infection caused by maternal chromosomally integrated virus. Hall CB, Caserta MT, Schnabel KC, Shelley LM, Carnahan JA, Marino AS, Yoo C, Lofthus GK, J Infect Dis 2010 201 505 507 10.1086/650495 20088693
24. The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Arbuckle JH, Medveczky MM, Luka J, Hadley SH, Luegmayr A, Ablashi D, Lund TC, Tolar J, De Meirleir K, Montoya JG, et al. Proc Natl Acad Sci USA 2010 107 5563 5568 10.1073/pnas.0913586107 20212114
25. Association of HHV-6 and HHV-7 reactivation with the development of chronic allograft nephropathy. Chapenko S, Folkmane I, Ziedina I, Chistyakovs M, Rozentals R, Krumina A, Murovska M, J Clin Virol 2009 46 29 32 10.1016/j.jcv.2009.05.018 19497784
26. Quantitative HHV-6B antigenemia test for the monitoring of transplant patients. Loginov R, Karlsson T, Hockerstedt K, Ablashi D, Lautenschlager I, Eur J Clin Microbiol Infect Dis 2010
27. Human herpesvirus-6 and -7 in transplantation. Dockrell DH, Paya CV, Rev Med Virol 2001 11 23 36 10.1002/rmv.299 11241800 (Pubitemid 32126887)
28. Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of Sub-Saharan Africa. Bates M, Monze M, Bima H, Kapambwe M, Clark D, Kasolo FC, Gompels UA, J Med Virol 2009 81 779 789 10.1002/jmv.21455 19319952
29. Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey. Yalcin S, Karpuzoglu T, Suleymanlar G, Mutlu G, Mukai T, Yamamoto T, Isegawa Y, Yamanishi K, Arch Virol 1994 136 183 190 10.1007/BF01538827 8002785 (Pubitemid 2090289)
30. A reverse transcription-nested PCR assay for HHV-6 mRNA early transcript detection after transplantation. Pradeau K, Bordessoule D, Szelag JC, Rolle F, Ferrat P, Le Meur Y, Turlure P, Denis F, Ranger-Rogez S, J Virol Methods 2006 134 41 47 10.1016/j.jviromet.2005.11.015 16417932 (Pubitemid 44294304)
31. Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. Boutolleau D, Duros C, Bonnafous P, Caiola D, Karras A, Castro ND, Ouachee M, Narcy P, Gueudin M, Agut H, Gautheret-Dejean A, J Clin Virol 2006 35 257 263 10.1016/j.jcv.2005.08.002 16183328 (Pubitemid 43188970)